The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion
Open accessAbstract
Interferon-γ (IFN-γ) is a pleiotropic cytokine that has long been praised as an important effector molecule of anti-tumor immunity, capable of suppressing tumor growth through various mechanisms. On the contrary to such a bright side of IFN-γ, it has also been involved in promoting an outgrowth of tumor cells with immunoevasive phenotype suggesting an existence of a dark “tumor-promoting” side effect of IFN-γ. In this review, we will summarize this multi-functional role of IFN-γ in tumor context, how it promotes changes in tumor phenotype towards increased fitness for growth in immunocompetent host. Furthermore, we summarize how IFN-γ is involved in homeostatic or cancer-triggered mechanisms to establish an immunosuppressive tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Sharma, P., Hu-Lieskovan, S., Wargo, J. A., & Ribas, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.017 · Cited by 5,588
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Ayers, M., Lunceford, J., Nebozhyn, M., Murphy, E., Loboda, A., Kaufman, D. R., Albright, A., Cheng, J. D., Kang, S. P., Shankaran, V., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91190 · Cited by 3,788
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Garcia-Diaz, A., Shin, D. S., Moreno, B. H., Saco, J., Escuin-Ordinas, H., Rodriguez, G. A., Zaretsky, J. M., Sun, L., Hugo, W., Wang, X., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.031 · Cited by 1,942
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Ostrand-Rosenberg, S., & Sinha, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802740 · Cited by 1,736
Spranger, S., Spaapen, R. M., Zha, Y., Williams, J., Meng, Y., Ha, T. T., & Gajewski, T. F. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006504 · Cited by 1,677
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Adaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
Shin, D. S., Zaretsky, J. M., Escuin-Ordinas, H., Garcia-Diaz, A., Hu-Lieskovan, S., Kalbasi, A., Grasso, C. S., Hugo, W., Sandoval, S., Torrejon, D. Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1223 · Cited by 1,337
Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy
Gao, J., Shi, L. Z., Zhao, H., Chen, J., Xiong, L., He, Q., Chen, T., Roszik, J., Bernatchez, C., Woodman, S. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.069 · Cited by 1,300
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Benci, J. L., Xu, B., Qiu, Y., Wu, T. J., Dada, H., Twyman-Saint Victor, C., Cucolo, L., Lee, D. S. M., Pauken, K. E., Huang, A. C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.022 · Cited by 1,216
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Manguso, R. T., Pope, H. W., Zimmer, M. D., Brown, F. D., Yates, K. B., Miller, B. C., Collins, N. B., Bi, K., LaFleur, M. W., Juneja, V. R., et al. (2017) · Nature · doi:10.1038/nature23270 · Cited by 1,147
The roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899
Identification of essential genes for cancer immunotherapy
Patel, S. J., Sanjana, N. E., Kishton, R. J., Eidizadeh, A., Vodnala, S. K., Cam, M., Gartner, J. J., Jia, L., Steinberg, S. M., Yamamoto, T. N., et al. (2017) · Nature · doi:10.1038/nature23477 · Cited by 870
Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis
Chawla-Sarkar, M., Lindner, D. J., Liu, Y.-F., Williams, B. R., Sen, G. C., Silverman, R. H., & Borden, E. C. (2003) · Apoptosis · doi:10.1023/a:1023668705040 · Cited by 829
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
Abiko, K., Matsumura, N., Hamanishi, J., Horikawa, N., Murakami, R., Yamaguchi, K., Yoshioka, Y., Baba, T., Konishi, I., & Mandai, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.101 · Cited by 725
Chin, Y. E., Kitagawa, M., Su, W.-C. S., You, Z.-H., Iwamoto, Y., & Fu, X.-Y. (1996) · Science · doi:10.1126/science.272.5262.719 · Cited by 696
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
Isaacs, A., & Lindenmann, J. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602
The Two Faces of Interferon-γ in Cancer
Zaidi, M. R., & Merlino, G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0482 · Cited by 593
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572
Interferon-γ, a Th1 Cytokine, Regulates Fat Inflammation: A Role for Adaptive Immunity in Obesity
Rocha, V. Z., Folco, E. J., Sukhova, G., Shimizu, K., Gotsman, I., Vernon, A. H., & Libby, P. (2008) · Circulation Research · doi:10.1161/circresaha.108.177105 · Cited by 523
Roles of regulatory T cells in cancer immunity
Takeuchi, Y., & Nishikawa, H. (2016) · International Immunology · doi:10.1093/intimm/dxw025 · Cited by 523
Angelova, M., Charoentong, P., Hackl, H., Fischer, M. L., Snajder, R., Krogsdam, A. M., Waldner, M. J., Bindea, G., Mlecnik, B., Galon, J., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0620-6 · Cited by 522
Multiple roles for CD4+ T cells in anti‐tumor immune responses
Kennedy, R., & Celis, E. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00616.x · Cited by 511
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Holmgaard, R. B., Zamarin, D., Li, Y., Gasmi, B., Munn, D. H., Allison, J. P., Merghoub, T., & Wolchok, J. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.077 · Cited by 482
γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity
Gao, Y., Yang, W., Pan, M., Scully, E., Girardi, M., Augenlicht, L. H., Craft, J., & Yin, Z. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030584 · Cited by 453
Rüegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P., & Lejeune, F. J. (1998) · Nature Medicine · doi:10.1038/nm0498-408 · Cited by 450
The determinants of tumour immunogenicity
Blankenstein, T., Coulie, P. G., Gilboa, E., & Jaffee, E. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3246 · Cited by 441
Morel, S., Lévy, F., Burlet-Schiltz, O., Brasseur, F., Probst-Kepper, M., Peitrequin, A.-L., Monsarrat, B., Van Velthoven, R., Cerottini, J.-C., Boon, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80163-6 · Cited by 415
A novel dendritic cell subset involved in tumor immunosurveillance
Taieb, J., Chaput, N., Ménard, C., Apetoh, L., Ullrich, E., Bonmort, M., Péquignot, M., Casares, N., Terme, M., Flament, C., et al. (2006) · Nature Medicine · doi:10.1038/nm1356 · Cited by 405
Dendritic cells: Understanding immunogenicity
Steinman, R. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200737400 · Cited by 401
Role of interferon-gamma in immune cell regulation.
Young, H. A., & Hardy, K. J. (1995) · PubMed · Cited by 375
Goldberg, M. V., & Drake, C. G. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_114 · Cited by 337
The role of gamma interferon in antimicrobial immunity
Shtrichman, R., & Samuel, C. E. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00199-5 · Cited by 334
Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
Granier, C., De Guillebon, E., Blanc, C., Roussel, H., Badoual, C., Colin, E., Saldmann, A., Gey, A., Oudard, S., & Tartour, E. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000213 · Cited by 324
Chapter 8 The Role of NKT Cells in Tumor Immunity
(2008) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)00408-9 · Cited by 316
Role of interferon-γ in immune cell regulation
Young, H. A., & Hardy, K. J. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.4.373 · Cited by 310
Bellucci, R., Martin, A., Bommarito, D., Wang, K., Hansen, S. H., Freeman, G. J., & Ritz, J. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008824 · Cited by 307
Miller, C. H. T., Maher, S. G., & Young, H. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05069.x · Cited by 303
Interferon Gamma in Successful Pregnancies1
Murphy, S. P., Tayade, C., Ashkar, A. A., Hatta, K., Zhang, J., & Croy, B. A. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.073353 · Cited by 303
Interferon-γ links ultraviolet radiation to melanomagenesis in mice
Zaidi, M. R., Davis, S., Noonan, F. P., Graff-Cherry, C., Hawley, T. S., Walker, R. L., Feigenbaum, L., Fuchs, E., Lyakh, L., Young, H. A., et al. (2011) · Nature · doi:10.1038/nature09666 · Cited by 293
Algarra, I., Garc�a-Lora, A., Cabrera, T., Ruiz-Cabello, F., & Garrido, F. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0517-9 · Cited by 293
IFNγ signaling—Does it mean JAK–STAT?
Gough, D. J., Levy, D. E., Johnstone, R. W., & Clarke, C. J. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.08.004 · Cited by 289
Maeurer, M. J., Gollin, S. M., Martin, D., Swaney, W., Bryant, J., Castelli, C., Robbins, P., Parmiani, G., Storkus, W. J., & Lotze, M. T. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118958 · Cited by 289
Genetic and Clonal Dissection of Murine Small Cell Lung Carcinoma Progression by Genome Sequencing
McFadden, D. G., Papagiannakopoulos, T., Taylor-Weiner, A., Stewart, C., Carter, S. L., Cibulskis, K., Bhutkar, A., McKenna, A., Dooley, A., Vernon, A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.031 · Cited by 288
MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis
Hemon, P., Jean-Louis, F., Ramgolam, K., Brignone, C., Viguier, M., Bachelez, H., Triebel, F., Charron, D., Aoudjit, F., Al-Daccak, R., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002050 · Cited by 252
A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells.
Qin, Z., Schwartzkopff, J., Pradera, F., Kammertoens, T., Seliger, B., Pircher, H., & Blankenstein, T. J. F. (2003) · PubMed · Cited by 235
Human Tumor Antigens and Cancer Immunotherapy
Vigneron, N. (2015) · BioMed Research International · doi:10.1155/2015/948501 · Cited by 228
Tricking the balance: NK cells in anti-cancer immunity
Pahl, J., & Cerwenka, A. (2017) · Immunobiology · doi:10.1016/j.imbio.2015.07.012 · Cited by 205
SOCS, inflammation, and cancer
Inagaki-Ohara, K., Kondo, T., Ito, M., & Yoshimura, A. (2013) · JAK-STAT · doi:10.4161/jkst.24053 · Cited by 194
IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice
Hanada, T., Kobayashi, T., Chinen, T., Saeki, K., Takaki, H., Koga, K., Minoda, Y., Sanada, T., Yoshioka, T., Mimata, H., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060436 · Cited by 187
IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment
Nirschl, C. J., Suárez-Fariñas, M., Izar, B., Prakadan, S., Dannenfelser, R., Tirosh, I., Liu, Y., Zhu, Q., Devi, K. S. P., Carroll, S. L., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.016 · Cited by 182
SOCS1 Is a Suppressor of Liver Fibrosis and Hepatitis-induced Carcinogenesis
Yoshida, T., Ogata, H., Kamio, M., Joo, A., Shiraishi, H., Tokunaga, Y., Sata, M., Nagai, H., & Yoshimura, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031675 · Cited by 180
Jürgens, B., Hainz, U., Fuchs, D., Felzmann, T., & Heitger, A. (2009) · Blood · doi:10.1182/blood-2008-12-195073 · Cited by 176
Derré, L., Corvaisier, M., Charreau, B., Moreau, A., Godefroy, E., Moreau-Aubry, A., Jotereau, F., & Gervois, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3100 · Cited by 174
Brody, J. R., Costantino, C. L., Berger, A. C., Sato, T., Lisanti, M. P., Yeo, C. J., Emmons, R. V., & Witkiewicz, A. K. (2009) · Cell Cycle · doi:10.4161/cc.8.12.8745 · Cited by 174
IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
Takeda, K., NAKAYAMA, M., Hayakawa, Y., Kojima, Y., Ikeda, H., Imai, N., Ogasawara, K., Okumura, K., Thomas, D. M., & Smyth, M. J. (2017) · Nature Communications · doi:10.1038/ncomms14607 · Cited by 171
Self-citationPujade-Lauraine, E., Guastalla, J. P., Colombo, N., Devillier, P., François, E., Fumoleau, P., Monnier, A., Nooy, M., Mignot, L., Bugat, R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.343 · Cited by 158
The role of interferon-gamma on immune and allergic responses
Teixeira, L. K., Fonseca, B. P., Barboza, B. A., & Viola, J. P. B. (2005) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762005000900024 · Cited by 154
Wang, L., Zhao, Y., Liu, Y. F., Akiyama, K., Chen, C., Qu, C., Jin, Y. J., & Shi, S. (2013) · Stem Cells · doi:10.1002/stem.1388 · Cited by 151
Tumor Rejection by Disturbing Tumor Stroma Cell Interactions
Ibe, S., Qin, Z., Schüler, T., Preiß, S., & Blankenstein, T. J. F. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.11.1549 · Cited by 149
Martini, M., Testi, M. G., Pasetto, M., Picchio, M. C., Innamorati, G., Mazzocco, M., Ugel, S., Cingarlini, S., Bronte, V., Zanovello, P., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.007 · Cited by 137
Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4
Mo, X., Zhang, H., Preston, S., Martin, K. A., Zhou, B., Vadalia, N., Gamero, A. M., Soboloff, J., Tempera, I., & Zaidi, M. R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1615 · Cited by 133
Alberts, D. S., Marth, C., Alvarez, R. D., Johnson, G. A., Bidziński, M., Kardatzke, D. R., Bradford, W. Z., Loutit, J. S., Kirn, D. H., Clouser, M. C., et al. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.005 · Cited by 127
Innate lymphoid cells: new insights into function and development
Cortez, V. S., Robinette, M. L., & Colonna, M. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.01.004 · Cited by 125
Gupta, H. B., Clark, C. A., Yuan, B., Sareddy, G. R., Pandeswara, S., Padron, A. S., Hurez, V. J., Conejo-Garcia, J. R., Vadlamudi, R. K., Li, R., et al. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.30 · Cited by 122
Beatty, G. L., & Paterson, Y. Y. W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5502 · Cited by 119
Spear, P., Barber, A., Rynda‐Apple, A., & Sentman, C. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103019 · Cited by 119
Taniguchi, K., Petersson, M., Höglund, P., Kiessling, R. W., Klein, G., & Kärre, K. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3405 · Cited by 114
Meyskens, F. L., Kopecky, K. J., Taylor, C. W., Noyes, R. D., Tuthill, R. J., Hersh, E. M., Feun, L. G., Doroshow, J. H., Flaherty, L. E., & Sondak, V. K. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.22.1710 · Cited by 109
Harvat, B. L., Seth, P. K., & Jetten, A. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201055 · Cited by 98
Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene
Lollini, P., Bosco, M. C., Cavallo, F., Giovanni, C. D., Giovarelli, M., Landuzzi, L., Musiani, P., Modesti, A., Nicoletti, G., Palmieri, G., et al. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550224 · Cited by 96
Interferon gamma in autoimmunity: A complicated player on a complex stage
Lees, J. R. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.014 · Cited by 90
Efficacy of CAR T-cell Therapy in Large Tumors Relies upon Stromal Targeting by IFNγ
Textor, A., Listopad, J. J., Wührmann, L. L., Pérez, C., Kruschinski, A., Chmielewski, M. M., Abken, H., Blankenstein, T. J. F., & Charo, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0079 · Cited by 88
Schürch, C. M., Riether, C., Amrein, M. A., & Ochsenbein, A. F. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20121229 · Cited by 83
Herlyn, M., Guerry, D., & Koprowski, H. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.4226 · Cited by 82
Garbe, C., Krasagakis, K., Zouboulis, C. C., Schröder, K., Krüger, S., Stadler, R., & Orfanos, C. E. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12875837 · Cited by 82
Matsushita, K., Takenouchi, T., Shimada, H., Tomonaga, T., Hayashi, H., Shioya, A., Komatsu, A., Matsubara, H., & Ochiai, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2006.00137.x · Cited by 82
He, Y., Wang, X., Zhang, G., Chen, H., Zhang, H., & Feng, Z. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0654-1 · Cited by 78
Giannopoulos, A., Constantinides, C. A., Fokaeas, E., Stravodimos, C., Giannopoulou, M., Kyroudi, A., & Gounaris, A. (2003) · PubMed · Cited by 75
Schiller, J. H., Pugh, M., Kirkwood, J. M., Karp, D. D., Larson, M., & Borden, E. C. (1996) · PubMed · Cited by 66
Meyskens, F. L., Kopecky, K. J., Samson, M. K., Hersh, E., Macdonald, J. S., Jaffe, H. S., Crowley, J. J., & Coltman, C. A. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.12.1071-a · Cited by 66
Wiesenfeld, M., O'Connell, M. J., Wieand, H. S., Gonchoroff, N. J., Donohue, J. H., Fitzgibbons, R. J., Krook, J. E., Mailliard, J. A., Gerstner, J. B., & Pazdur, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2324 · Cited by 64
Marth, C., Windbichler, G. H., Hausmaninger, H., Petru, E., Estermann, K., Pelzer, A. E., & Mueller‐Holzner, E. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00622.x · Cited by 63
Interferon γ limits the effectiveness of melanoma peptide vaccines
Cho, H.-I., Lee, Y.-R., & Celis, E. (2010) · Blood · doi:10.1182/blood-2010-08-298117 · Cited by 61
Poole, I. C. L., Riker, A. I., Quevedo, M. E., Stennett, L. S., Wang, E., Marincola, F. M., Kast, W. M., Robinson, J. K., & Nickoloff, B. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64871-7 · Cited by 55
Ernstoff, M. S., Trautman, T., Davis, C. A., Reich, S. D., Witman, P. A., Balser, J. P., Rudnick, S., & Kirkwood, J. M. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.11.1804 · Cited by 54
Zou, Q., Jin, J., Xiao, Y., Zhou, X., Hu, H., Cheng, X., Kazimi, N., Ullrich, S. E., & Sun, S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.046 · Cited by 53
Loss of IFNγ Receptor Is an Independent Prognostic Factor in Ovarian Cancer
Duncan, T. J., Rolland, P., Deen, S., Scott, I., Liu, D. T. Y., Spendlove, I., & Durrant, L. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2833 · Cited by 48
Street, D. G., Kaufmann, A. M., Vaughan, A. T., Fisher, S. G., Hunter, M., Schreckenberger, C., Potkul, R. K., Gissmann, L., & Qiao, L. (1997) · Gynecologic Oncology · doi:10.1006/gyno.1997.4667 · Cited by 45
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.
Et, C., Ahmann, D. L., Long, H. J., Frytak, S., Sherwin, S. A., & Mn, C. (1987) · PubMed · Cited by 41
Niccolai, E., Taddei, A., Ricci, F., Rolla, S., D’Elios, M. M., Benagiano, M., Bechi, P., Bencini, L., Ringressi, M. N., Pini, A., et al. (2015) · Clinical Science · doi:10.1042/cs20150437 · Cited by 36
Harden, J. L., Gu, T., Kilinc, M. O., Rowswell-Turner, R. B., Virtuoso, L. P., & Egilmez, N. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100168 · Cited by 34
Cited by
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Jhunjhunwala, S., Hammer, C., & Delamarre, L. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00339-z · Cited by 1,490
Roles of IFN-γ in tumor progression and regression: A review
Jorgovanovic, D., Song, M., Wang, L., & Zhang, Y. (2020) · Biomarker Research · doi:10.1186/s40364-020-00228-x · Cited by 1,234
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Korman, A. J., Garrett-Thomson, S. C., & Lonberg, N. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00345-8 · Cited by 548
Targeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 455
Gangoso, E., Southgate, B., Bradley, L., Rus, S., Galvez-Cancino, F., McGivern, N., Güç, E., Kapourani, C.-A., Byron, A., Ferguson, K. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.023 · Cited by 359
Metadata
- Authors
- Mojic, M., Takeda, K., & Hayakawa, Y.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-12-28
- Volume
- 19
- Issue
- 1
- Pages
- 89
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2781052937
- Cited by
- 334
- References
- 101
- FWCI
- 10.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.